Intervention Protocol

Behavioural therapies versus treatment as usual for depression

  1. Deborah Caldwell1,
  2. Vivien Hunot2,
  3. Theresa HM Moore2,
  4. Philippa Davies2,
  5. Hannah Jones3,
  6. Glyn Lewis1,
  7. Rachel Churchill2,*

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 8 SEP 2010

DOI: 10.1002/14651858.CD008697

How to Cite

Caldwell D, Hunot V, Moore THM, Davies P, Jones H, Lewis G, Churchill R. Behavioural therapies versus treatment as usual for depression (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD008697. DOI: 10.1002/14651858.CD008697.

Author Information

  1. 1

    University of Bristol, School of Social and Community Medicine, Bristol, Avon, UK

  2. 2

    University of Bristol, Academic Unit of Psychiatry, School of Social and Community Medicine, Bristol, Avon, UK

  3. 3

    The University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

*Rachel Churchill, Academic Unit of Psychiatry, School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol, Avon, BS8 2BN, UK. rachel.churchill@ccdan.org. rachel.churchill@bristol.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 SEP 2010

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To examine the effectiveness and acceptability of all BT approaches compared with treatment as usual/waiting list/attention placebo control conditions for acute depression.
  2. To examine the effectiveness and acceptability of different BT approaches (behavioural therapy, behavioural activation, social skills training and relaxation training) compared with treatment as usual/waiting list/attention placebo control conditions for acute depression.
  3. To examine the effectiveness and acceptability of all BT approaches compared with different types of comparator (standard care, no treatment, waiting list, attention placebo) for acute depression.